Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55,860 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction.
Wang Y, Xie Z, Jiang N, Wu Z, Xue R, Dong B, Fan W, Dai G, Chen C, Li J, Chen H, Ye Z, Fang R, Choy M, Zhao J, Dong Y, Liu C. Wang Y, et al. Among authors: zhao j. Front Cardiovasc Med. 2020 Nov 26;7:582890. doi: 10.3389/fcvm.2020.582890. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33324687 Free PMC article.
BMP9-induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus-associated hepatocellular carcinoma.
Han Y, Pan Q, Guo Z, Du Y, Zhang Y, Liu Y, Zhao J, Xu J, Yang J, Ouyang D, Tang Y, Wang Q, Li Y, He J, Yang M, Chen H, Yang C, Yang X, You J, Chen Y, Ren M, Zhu Y, Xia J, Xiang T. Han Y, et al. Among authors: zhao j. Clin Transl Med. 2023 May;13(5):e1247. doi: 10.1002/ctm2.1247. Clin Transl Med. 2023. PMID: 37132170 Free PMC article.
Correction: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
Zhu Q, Zhong AL, Hu H, Zhao JJ, Weng DS, Tang Y, Pan QZ, Zhou ZQ, Song MJ, Yang JY, He JY, Liu Y, Li M, Hu WM, Yang CP, Xiang T, Chen MY, Ma G, Guo L, Xia JC. Zhu Q, et al. J Hematol Oncol. 2023 Nov 4;16(1):110. doi: 10.1186/s13045-023-01505-6. J Hematol Oncol. 2023. PMID: 37925485 Free PMC article. No abstract available.
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
Pan QZ, Zhao JJ, Liu L, Zhang DS, Wang LP, Hu WW, Weng DS, Xu X, Li YZ, Tang Y, Zhang WH, Li JY, Zheng X, Wang QJ, Li YQ, Xiang T, Zhou L, Yang SN, Wu C, Huang RX, He J, Du WJ, Chen LJ, Wu YN, Xu B, Shen Q, Zhang Y, Jiang JT, Ren XB, Xia JC. Pan QZ, et al. Among authors: zhao jj. Signal Transduct Target Ther. 2024 Apr 3;9(1):79. doi: 10.1038/s41392-024-01788-2. Signal Transduct Target Ther. 2024. PMID: 38565886 Free PMC article. Clinical Trial.
55,860 results
You have reached the last available page of results. Please see the User Guide for more information.